CIK 0000059478 · Pharmaceutical Preparations (SIC 2834) · NYSE · incorporated in IN · fiscal year ends 12/31
| FY2025 | FY2024 | |
|---|---|---|
| Revenue (USD) | 65.2 B | 28.5 B |
| Net income (USD) | 20.6 B | 6.2 B |
| Diluted EPS (USD/shares) | 22.95 | 6.9 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-20 | 4 | FORM 4 | 2026-10-19 |
| 2026-10-20 | 4 | FORM 4 | 2026-10-19 |
| 2026-10-20 | 4 | FORM 4 | 2026-10-19 |
| 2026-10-20 | 4 | FORM 4 | 2026-10-19 |
| 2026-10-19 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-10-16 | SCHEDULE 13D | SCHEDULE 13D | |
| 2026-10-15 | 144 | 144 | |
| 2026-10-08 | 3 | FORM 3 | 2026-10-08 |
| 2026-10-07 | 144 | 144 | |
| 2026-09-22 | 4 | FORM 4 | 2026-09-21 |
| 2026-09-22 | 4 | FORM 4 | 2026-09-21 |
| 2026-09-22 | 4 | FORM 4 | 2026-09-21 |
| 2026-09-22 | 4 | FORM 4 | 2026-09-21 |
| 2026-09-11 | 4 | FORM 4 | 2025-09-22 |
| 2026-09-04 | 3/A | FORM 3/A | 2025-11-07 |
| 2026-09-04 | 4 | FORM 4 | 2026-09-02 |
| 2026-09-04 | 4 | FORM 4 | 2026-09-02 |
| 2026-08-18 | 4 | FORM 4 | 2026-08-17 |
| 2026-08-18 | 4 | FORM 4 | 2026-08-17 |
| 2026-08-18 | 4 | FORM 4 | 2026-08-17 |
| 2026-08-18 | 4 | FORM 4 | 2026-08-17 |
| 2026-08-18 | 4 | FORM 4 | 2026-08-17 |
| 2026-08-17 | 144 | 144 | |
| 2026-08-11 | 4 | FORM 4 | 2026-08-10 |
| 2026-08-10 | 144 | 144 |
Forms on file (last 1,000): 4 693, 144 70, 8-K 43, SC TO-T/A 23, SC 13G/A 22, PX14A6G 17, 3 15, 10-Q 14. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=LLY (0.002 USD), /gw/filings/filings?ticker=LLY&form=8-K, /gw/filings/facts?ticker=LLY&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange